Acyl hydroxypyrazoles as novel agonists for high-affinity nicotinic acid receptor GPR109A: WO2008051403. - Wikidata - awgldk - TriplyDB

Acyl hydroxypyrazoles as novel agonists for high-affinity nicotinic acid receptor GPR109A: WO2008051403.

Acyl hydroxypyrazoles as novel agonists for high-affinity nicotinic acid receptor GPR109A: WO2008051403.

http://www.wikidata.org/entity/Q37536057

about

Acyl hydroxypyrazoles as novel agonists for high-affinity nicotinic acid receptor GPR109A: WO2008051403.

http://www.wikidata.org/entity/Q37536057

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Acyl hydroxypyrazoles as novel ...... eceptor GPR109A: WO2008051403.

@en

Acyl hydroxypyrazoles as novel ...... eceptor GPR109A: WO2008051403.

@nl

type

label

Acyl hydroxypyrazoles as novel ...... eceptor GPR109A: WO2008051403.

@en

Acyl hydroxypyrazoles as novel ...... eceptor GPR109A: WO2008051403.

@nl

prefLabel

Acyl hydroxypyrazoles as novel ...... eceptor GPR109A: WO2008051403.

@en

Acyl hydroxypyrazoles as novel ...... eceptor GPR109A: WO2008051403.

@nl

P1433

Q37536057-7E64A4B5-C17D-40B8-AFEA-787C8E8CF8D3

P1476

Q37536057-29EA0E9A-8FA7-4497-9D49-628A0F5BE427

P2093

Q37536057-00ED858C-C6DC-4C47-A177-4EBDFFF0B8BF

P2860

Q37536057-0C1F93AE-617C-4F03-950E-944E7A9B58B4

Q37536057-0E886B5B-E4CA-4BDB-9BC4-D1D435A0B95D

Q37536057-0F977C8A-47E6-4782-96C5-9DBE49149E53

Q37536057-3E8D90CA-CDEA-45F0-819E-CDFF1FFA9C2C

Q37536057-4631666C-FC75-4E84-B0DE-56F3716D98B6

Q37536057-4C8021D2-F6FB-4CC6-8A8F-27DD60711DB1

Q37536057-679889E6-C2FB-4E8A-9A23-768F6FAE6ADB

Q37536057-688EC7D1-0809-497B-88B0-BFDFC5C5186E

Q37536057-826F668A-F57D-4441-9B3E-F29F3615F8BD

Q37536057-A76F226F-E25E-4DA8-BA8C-23BEFCD12263

P304

Q37536057-BAFBDCB4-E13C-4C78-8797-1113E80AF804

P31

Q37536057-CE7391D2-B26B-4B5D-9C02-320D0E410C38

P356

Q37536057-22F49A59-B245-49AD-81A8-C344BC2F72A3

P407

Q37536057-7E4C9F53-32B1-40B0-9205-CAB480B74D27

P433

Q37536057-A38150F5-0344-4997-9D7A-E031A21E6B25

P478

Q37536057-020329FC-5FAF-4483-A032-73FF2FC4FAA9

P577

Q37536057-A5F4E737-469B-4C02-9BAA-BE522BA6C0FD

P698

Q37536057-EF637A7D-4624-4999-9BE0-B8FB4A7D968F

P356

13543770902798061

P1433

Expert Opinion on Therapeutic Patents

P1476

Acyl hydroxypyrazoles as novel ...... eceptor GPR109A: WO2008051403.

@en

P2093

Hong C Shen

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular identification of high and low affinity receptors for nicotinic acid

PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect

Drug treatment of lipid disorders.

Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review.

The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target.

Nicotinic acid receptor agonists.

Effects of a niacin receptor partial agonist, MK-0354, on plasma free fatty acids, lipids, and cutaneous flushing in humans.

One-year reduction and longitudinal analysis of carotid intima-media thickness associated with colestipol/niacin therapy.

3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in mice.

Molecular modeling aided design of nicotinic acid receptor GPR109A agonists.

P304

1149-1155

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543770902798061

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2009-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19566484

http://www.w3.org/2001/XMLSchema#string